Form D · Other Health Care
JenaValve Technology Inc
Irvine, CA · CIK 0001377801
Offering snapshot reported Apr 8, 2024 · SEC filing
- Reported sold
- $100M Offering amount: $100M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 21, 2021 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$73,879,990 → $100,400,000
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 8, 2024 | Amendment | $100,400,000 | $26,520,010vs Sep 2, 2022 | 17 | SEC filing |
| Sep 2, 2022 | Amendment | $73,879,990 | $65,879,986vs Jan 4, 2022 | 17 | SEC filing |
| Jan 4, 2022 | Initial | $8,000,004 | No comparison | 1 | SEC filing |
| Oct 7, 2020 | Amendment | $66,499,987 | $30,999,996vs Feb 13, 2020 | 8 | SEC filing |
| Feb 13, 2020 | Initial | $35,499,991 | No comparison | 1 | SEC filing |
| Jun 21, 2019 | Initial | $14,491,952 | No comparison | 10 | SEC filing |
| Jul 25, 2018 | Amendment | $14,332,617 | $9,437,017vs Feb 6, 2018 | 11 | SEC filing |
| Feb 6, 2018 | Initial | $4,895,600 | No comparison | 11 | SEC filing |
| Aug 2, 2017 | Initial | $9,392,769 | No comparison | 14 | SEC filing |
| Aug 11, 2016 | Initial | $9,998,240 | No comparison | 11 | SEC filing |
| Aug 7, 2015 | Initial | $26,500,083 | No comparison | 13 | SEC filing |
| Nov 14, 2014 | Amendment | $73,373,696 | $10,875,953vs Jul 24, 2013 | 15 | SEC filing |
| Jul 24, 2013 | Initial | $62,497,743 | No comparison | 13 | SEC filing |
| Mar 12, 2010 | Initial | $13,533,998 | No comparison | 5 | SEC filing |
| Oct 2, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 2, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $525K
- Finders' fees
- $0
- Form D file number
- 021-427847
Source: Form D, filed Apr 8, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Erik Amble | Director |
| Peter Barrett | Director |
| Jose Calle Gordo | Director |
| Jose (Pepe) Calle Gordo | Director |
| Victoria Carr Brendel | Executive |
| Raymond Cohen | Director |
| Keith Dawkins | Director |
| Daniel Dearen | Director |
| Michael Dormer | Director |
| David Drachman | Director, Executive |
| Markus Ferrari | Director |
| Hans Reiner Figulla | Director |
| Carl Christian Gilhuus Moe | Director |
| Andrew Hack | Director |
| Regina Hodits | Director |
| Arnd Kaltofen | Director |
| Jan Keltjens | Director |
| John Kilcoyne | Director, Executive |
| Olivier Litzka | Director |
| Kenneth Mac Leod | Director |
| Rudi Marien | Director |
| Robert Mitchell | Director |
| Kari Moore | Executive |
| Van Beneden Patrick | Director |
| Jan Pensaert | Director |
| Helmut Straubinger | Director, Executive |
| Patrick Van Beneden | Director |
| Stephan Wehselau | Executive |
| Peter Wulff | Executive |
| Ouyang Xiangyu | Director |
| Quan Zhou | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
4 Cromwell
Irvine, CA, 92618
Irvine, CA, 92618